Drug Interaction Report

Buprenorphine and Butorphanol: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Buprenorphine

Belbuca Brixadi Buprenex BuTrans Simbadol Sublocade Zorbium
+

Butorphanol

Butorphic Dolorex Solution Torbugesic Torphadine Vetorphic
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 633 documented Buprenorphine interactions, 601 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be weaker
The Bottom Line
Buprenorphine and butorphanol compete at the same opioid receptors, so using them together can weaken pain relief, trigger withdrawal, and add a risk of serotonin syndrome; this combination is best avoided, so check with your prescriber.

Both buprenorphine and butorphanol are opioid pain medicines, but they work in an unusual way. Each one partly blocks the same opioid receptors it also turns on. When you take them together, one can push the other off those receptors. This can make your pain relief weaker than expected, and if you depend on one of them, it may trigger uncomfortable withdrawal symptoms like sweating, chills, belly cramps, or feeling anxious.

There is also a possible added risk of serotonin syndrome (things like agitation, fast heartbeat, shaking, or sweating). The good news: your doctor and pharmacist can manage this safely. Please don't stop anything on your own, just talk with them.

Direction: Both agents are mixed agonist/antagonist or partial agonist opioids acting at mu receptors. Co-administration produces competitive receptor antagonism, potentially reducing butorphanol's analgesic effect and precipitating withdrawal in opioid-dependent patients. Additive serotonergic activity raises serotonin syndrome risk. Neither is a relevant prodrug here.

  • Mechanism: opioid receptor competition plus additive serotonergic effects
  • Evidence: theoretical; severity major
  • Onset: unspecified
  • Management: avoid concomitant use. If serotonergic exposure is unavoidable, monitor closely during initiation/titration for clonus, hyperreflexia, autonomic instability, agitation; discontinue if serotonin syndrome is suspected.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

Reduced analgesic effect or precipitation of withdrawal symptoms, and an increased risk of serotonin syndrome

Interaction Deep Dive

Butorphanol should not be given together with a mixed opioid agonist/antagonist or a partial agonist opioid analgesic, because doing so may diminish the analgesic effect of butorphanol and could bring on withdrawal symptoms. In addition, when butorphanol is combined with other agents affecting the serotonergic system, monitor the patient closely, particularly at the start of therapy and during dose titration, since the likelihood of serotonin syndrome rises; treatment should be stopped if this condition is suspected21.

Why it happens (mechanism)

Opioid receptor antagonism; additive serotonergic effects

How to manage this interaction

Because these two opioids compete at the same receptors, combining them is generally something care teams try to avoid. Here is what typically happens:

  • Your prescriber may choose one agent instead of both, or select an alternative pain medicine.
  • If both are truly needed, your team may monitor you more closely, especially when starting or adjusting doses, and watch for withdrawal or signs of serotonin syndrome.
  • Any dose changes will be individualized by your care team.

Keep taking your medicines as prescribed, and tell your pharmacist or doctor right away if you notice weaker pain control, withdrawal symptoms, agitation, shaking, fast heartbeat, or heavy sweating.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Buprenorphine and Butorphanol together?

Buprenorphine and butorphanol compete at the same opioid receptors, so using them together can weaken pain relief, trigger withdrawal, and add a risk of serotonin syndrome; this combination is best avoided, so check with your prescriber. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Buprenorphine and Butorphanol interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Buprenorphine and Butorphanol interaction managed?

Because these two opioids compete at the same receptors, combining them is generally something care teams try to avoid. Here is what typically happens: Your prescriber may choose one agent instead of both, or select an alternative pain medicine. If both are truly needed, your team may monitor you more closely, especially when starting or adjusting doses, and watch for withdrawal or signs of seroto… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Buprenorphine or Butorphanol need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (2)

  1. Product Information: BUTRANS(R) transdermal system patch, buprenorphine transdermal system patch. Purdue Pharma L.P. (per FDA), Stamford, CT, 2016. DailyMed
  2. Product Information: BUPRENEX(R) intravenous injection, intramuscular injection, buprenorphine HCl intravenous injection, intramuscular injection. Indivior Inc. (per DailyMed), Richmond, VA, 2016. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.